Tag : myocardial infarction

Neurology

Suboptimal Diet May Drive $50 Billion in Cardiometabolic Costs

Newsemia
Poor diet is associated with 18.2% of all costs related to treatment of ischemic heart disease, stroke, and type 2 diabetes in the US, new...
Neurology

Mortality Sky-High After MI at Vascular Surgery, But MI Risk Low

Newsemia
Do the registry results mean practice is hitting a ‘natural limit’ on preoperative risk-factor management? Certainly, they suggest more can be done medically to protect...
Neurology

ORION-10: 58% Reduction in LDL With Inclisiran

Newsemia
A second phase 3 study has shown impressive reductions in LDL on top of statins with this novel agent given just twice a year. Medscape...
Neurology

No Increased CVD Event Risk With ADHD Meds in Kids With Autism

Newsemia
A database analysis of more than 300,000 individuals concludes there is no increased risk for adverse cardiovascular events associated with the use of stimulant medications...
Latest News

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Newsemia
Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding...
Neurology

New ADA Update: Liraglutide for Youth and Technology Issues

Newsemia
Liraglutide for youth, dulaglutide cardiovascular outcomes data, and ‘time-in-range’ guidelines inform the latest Living Standards updates. Medscape Medical News Source link...
Neurology

Testosterone replacement therapy associated with increased risk of stroke, heart attack

Newsemia
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack,...
Biology

Mouse HSA<sup>+</sup> immature cardiomyocytes persist in the adult heart and expand after ischemic injury

Newsemia
by Mariana Valente, Tatiana Pinho Resende, Diana Santos Nascimento, Odile Burlen-Defranoux, Francisca Soares-da-Silva, Benoit Dupont, Ana Cumano, Perpétua Pinto-do-Ó The assessment of the regenerative capacity...
Neurology

Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half

Newsemia
Restarting antiplatelet therapy after intracranial hemorrhage remains controversial, but new evidence suggests aspirin or clopidogrel can significantly reduce recurrent ICH without increased bleeding. Medscape Medical...
Neurology

Novel Antiplatelet Agent May Not Increase Bleeding Risk

Newsemia
Initial clinical results suggest that the new agent may be suitable for use with thrombolysis in acute ischemic stroke. Medscape Medical News Source link...
Neurology

PRAC Restricts Use of Alemtuzumab for MS Pending Ongoing Review

Newsemia
The EMA committee recommends updating the product information to note the potential for acute immune-mediated conditions, stroke, cervicocephalic arterial dissection, and severe neutropenia. News Alerts...
Latest News

Research: Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events

Newsemia
Taking a high dose of icosapent ethyl–a pure and stable prescription form of the omega-3 fatty acid known as EPA–significantly reduces the occurrence of first,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy